SPONSORED BY

Auto Segment
Mutual Fund Segment
My Budget
Expert Speak
In Association With
 
Business Standard

Sun Pharma rallies on FDA nod for cancer drug

USFDA have granted its subsidiary an approval for its ANDA for generic version of Doxil, Doxorubicin HCI liposome injection.

Related News

Sun Pharmaceutical Industries has rallied 4.4% to Rs 749 in morning trades after the company said US health regulators have approved a generic version of the drug Doxil.

“The U.S. Food and Drug Administration (USFDA) have granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) for generic version of Doxil, Doxorubicin HCI liposome injection,” said in a statement.

It will be available in 20 milligram and 50 milligram vials, it added.

Doxorubicin HCI liposome injection is used to treat patients with ovarian cancer that has progressed or recurred after platinum-based chemotherapy.

The stock opened at Rs 735 and touched high of Rs 752 on the NSE. A combined around 960,000 shares have changed hands on the counter in early morning deals on both the exchanges.

 

Read more on:   
|
|

Read More

UCO Bank slips on declining net

Shares of UCO Bank has slumped after the bank posted a sharp drop in net profit for the third quarter ended December 31, 2012.

Recommended for you

Quick Links

Market News

FMC-Sebi merger was needed: Samir Shah

This will pave the way for widening the scope of participation by banks, foreign institutional investors, mutual funds, etc, in the commodity ...

Budget And Impact: See-saw trade

Amid much volatility, the Nifty rose on Saturday. EY analyses the Budget impact:

Akash Prakash: Budget will keep the bulls happy

The Union Budget has, by and large, met most rational expectations of what could have been delivered. The arithmetic seems realistic, with gross ...

Nifty records best gain in five years on Budget day

Axis Bank, IndusInd Bank, Yes Bank, Kotak Mahindra Bank and ICICI Bank rallied between 4-9%

Nifty ends above 8,900 on growth oriented Budget; Axis Bank up 8%

The 30-share Sensex ended 141 points higher at 29,361 and the 50-share Nifty surged 57 points to close at 8,902.

 

Back to Top